Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandeep Sahay

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Respiratory Medicine|December 5, 2025
Vaccination utilization in patients with pulmonary hypertensionRodolfo A Estrada, Hasan Baher, Liwayway Andrade, et al.
Pulmonary Circulation|July 3, 2023
The cascade screening in heritable forms of pulmonary arterial hypertensionNidhy P Varghese, Akhilesh A Padhye, Pilar L Magoulas, et al.
Annals of the American Thoracic Society|August 10, 2023
Impact on Pulmonary Hypertension Hemodynamic Classification Based on the Methodology Used to Measure Pulmonary Artery Wedge Pressure and Cardiac OutputSandeep Sahay, James Lane, Megan G Sharpe, et al.
ERJ Open Research|October 21, 2020
ERS International Congress, Madrid, 2019: highlights from the Pulmonary Vascular Diseases AssemblySheila Ramjug, Jason Weatherald, Sandeep Sahay, et al.
Transplantation Direct|June 14, 2021
Causes and Circumstances of Death in Portopulmonary HypertensionSandeep Sahay, Sami Al Abdi, Celia Melillo, et al.
Annals of the American Thoracic Society|April 13, 2026
Rodatristat Ethyl Decreases Activity in Pulmonary Arterial Hypertension: Results from the ELEVATE-2 TrialDaniel J Lachant, Sandeep Sahay, Robert Block, et al.
Pulmonary Circulation|January 6, 2021
Impact of inhaled treprostinil on risk stratification with noninvasive parameters: a post hoc analysis of the TRIUMPH and BEAT studiesAdriano R Tonelli, Sandeep Sahay, Kathryn W Gordon, et al.
Chest|March 6, 2024
Comparison Between REVEAL Lite 2 and COMPERA 2.0 for Risk Stratification in Pulmonary Arterial HypertensionSandeep Sahay, Nelson Villasmil Hernandez, Fredrick Wang, et al.
Pulmonary Circulation|January 9, 2026
Global Resource Disparities Between Pulmonary Hypertension Centers: Results From the International Survey by the PVRI IDDI Access to Care WorkstreamSasha Z Prisco, Alexander Kantorovich, Yan Liu, et al.
The American Journal of Cardiology|May 21, 2020
PECAM-1 is Associated WithOutcomes and Response to Treatment in Pulmonary Arterial HypertensionKatharine R Clapham, Youlan Rao, Sandeep Sahay, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Respiratory Medicine|December 5, 2025
Vaccination utilization in patients with pulmonary hypertensionRodolfo A Estrada, Hasan Baher, Liwayway Andrade, et al.
Pulmonary Circulation|July 3, 2023
The cascade screening in heritable forms of pulmonary arterial hypertensionNidhy P Varghese, Akhilesh A Padhye, Pilar L Magoulas, et al.
Annals of the American Thoracic Society|August 10, 2023
Impact on Pulmonary Hypertension Hemodynamic Classification Based on the Methodology Used to Measure Pulmonary Artery Wedge Pressure and Cardiac OutputSandeep Sahay, James Lane, Megan G Sharpe, et al.
ERJ Open Research|October 21, 2020
ERS International Congress, Madrid, 2019: highlights from the Pulmonary Vascular Diseases AssemblySheila Ramjug, Jason Weatherald, Sandeep Sahay, et al.
Transplantation Direct|June 14, 2021
Causes and Circumstances of Death in Portopulmonary HypertensionSandeep Sahay, Sami Al Abdi, Celia Melillo, et al.
Annals of the American Thoracic Society|April 13, 2026
Rodatristat Ethyl Decreases Activity in Pulmonary Arterial Hypertension: Results from the ELEVATE-2 TrialDaniel J Lachant, Sandeep Sahay, Robert Block, et al.
Pulmonary Circulation|January 6, 2021
Impact of inhaled treprostinil on risk stratification with noninvasive parameters: a post hoc analysis of the TRIUMPH and BEAT studiesAdriano R Tonelli, Sandeep Sahay, Kathryn W Gordon, et al.
Chest|March 6, 2024
Comparison Between REVEAL Lite 2 and COMPERA 2.0 for Risk Stratification in Pulmonary Arterial HypertensionSandeep Sahay, Nelson Villasmil Hernandez, Fredrick Wang, et al.
Pulmonary Circulation|January 9, 2026
Global Resource Disparities Between Pulmonary Hypertension Centers: Results From the International Survey by the PVRI IDDI Access to Care WorkstreamSasha Z Prisco, Alexander Kantorovich, Yan Liu, et al.
The American Journal of Cardiology|May 21, 2020
PECAM-1 is Associated WithOutcomes and Response to Treatment in Pulmonary Arterial HypertensionKatharine R Clapham, Youlan Rao, Sandeep Sahay, et al.
Pageof 12